{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neisseria+Meningitidis", "query": { "condition": "Neisseria Meningitidis" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 30, "total_pages": 3, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Neisseria+Meningitidis&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-06-11T01:35:02.224Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00777790", "title": "Study of a Booster Dose of Meningococcal Diphtheria Toxoid Conjugate Vaccine in Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningitis", "Meningococcemia" ], "interventions": [ { "name": "Meningococcal Polysaccharide Diphtheria Toxoid Conjugate", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "13 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "13 Years to 21 Years" }, "enrollment_count": 241, "start_date": "2004-02", "completion_date": "2005-04", "has_results": true, "last_update_posted_date": "2014-02-14", "last_synced_at": "2026-06-11T01:35:02.224Z", "location_count": 9, "location_summary": "Atlanta, Georgia • Marietta, Georgia • Woburn, Massachusetts + 6 more", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Marietta", "state": "Georgia" }, { "city": "Woburn", "state": "Massachusetts" }, { "city": "Albany", "state": "New York" }, { "city": "Akron", "state": "Ohio" } ], "official_url": "https://clinicaltrials.gov/study/NCT00777790" }, { "nct_id": "NCT00345579", "title": "Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Haemophilus Influenzae Type b", "Neisseria Meningitidis" ], "interventions": [ { "name": "GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined 792014", "type": "BIOLOGICAL" }, { "name": "ActHIB", "type": "BIOLOGICAL" }, { "name": "Pediarix/Infanrix Penta", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 4432, "start_date": "2006-09", "completion_date": "2008-03", "has_results": true, "last_update_posted_date": "2016-12-16", "last_synced_at": "2026-06-11T01:35:02.224Z", "location_count": 61, "location_summary": "Birmingham, Alabama • Benton, Arkansas • Fayetteville, Arkansas + 51 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Benton", "state": "Arkansas" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Hot Springs", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00345579" }, { "nct_id": "NCT07197762", "title": "MenB-FHbp or MenACWY-TT/MenB-FHbp Vaccine in MenB-4C Primed Young Adults", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Neisseria Meningitidis" ], "interventions": [ { "name": "Trumenba", "type": "BIOLOGICAL" }, { "name": "PENBRAYA", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Emory University", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "25 Years", "sex": "ALL", "summary": "18 Years to 25 Years" }, "enrollment_count": 125, "start_date": "2025-11-04", "completion_date": "2026-12", "has_results": false, "last_update_posted_date": "2025-12-22", "last_synced_at": "2026-06-11T01:35:02.224Z", "location_count": 2, "location_summary": "Atlanta, Georgia", "locations": [ { "city": "Atlanta", "state": "Georgia" }, { "city": "Atlanta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT07197762" }, { "nct_id": "NCT00129129", "title": "Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Haemophilus Influenzae Type b", "Neisseria Meningitidis" ], "interventions": [ { "name": "GSK Biologicals' Haemophilus influenza type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine 792014 vaccine", "type": "BIOLOGICAL" }, { "name": "ActHIB", "type": "BIOLOGICAL" }, { "name": "Pediarix", "type": "BIOLOGICAL" }, { "name": "Prevnar", "type": "BIOLOGICAL" }, { "name": "Menomune", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "15 Months", "sex": "ALL", "summary": "6 Weeks to 15 Months" }, "enrollment_count": 756, "start_date": "2004-08-01", "completion_date": "2006-03-29", "has_results": true, "last_update_posted_date": "2018-08-24", "last_synced_at": "2026-06-11T01:35:02.224Z", "location_count": 27, "location_summary": "Little Rock, Arkansas • Fountain Valley, California • Centennial, Colorado + 19 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Centennial", "state": "Colorado" }, { "city": "Norwich", "state": "Connecticut" }, { "city": "Marietta", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00129129" }, { "nct_id": "NCT00471081", "title": "Immunogenicity and Safety of Meningococcal Vaccine GSK134612 Given as 1 or 2 Doses to Healthy 9-12 Months Old Toddlers.", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Infections, Meningococcal" ], "interventions": [ { "name": "Meningococcal vaccine GSK134612", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "9 Months", "maximum_age": "9 Months", "sex": "ALL", "summary": "9 Months to 9 Months" }, "enrollment_count": 385, "start_date": "2007-07-05", "completion_date": "2008-11-26", "has_results": true, "last_update_posted_date": "2019-06-25", "last_synced_at": "2026-06-11T01:35:02.224Z", "location_count": 19, "location_summary": "Birmingham, Alabama • Benton, Arkansas • Little Rock, Arkansas + 15 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Benton", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Antioch", "state": "California" }, { "city": "Fremont", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00471081" }, { "nct_id": "NCT00355121", "title": "Study of Menactra® in Children Aged 4 to 6 Years When Administered Concomitantly With a Fifth Dose of DAPTACEL®", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningococcal Meningitis", "Tetanus", "Diphtheria", "Pertussis", "Poliomyelitis" ], "interventions": [ { "name": "Polysaccharide Diphtheria Toxoid Conjugate Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "4 Years", "maximum_age": "7 Years", "sex": "ALL", "summary": "4 Years to 7 Years" }, "enrollment_count": 882, "start_date": "2006-10", "completion_date": "2009-07", "has_results": true, "last_update_posted_date": "2011-08-24", "last_synced_at": "2026-06-11T01:35:02.224Z", "location_count": 26, "location_summary": "Little Rock, Arkansas • Boulder, Colorado • Atlanta, Georgia + 23 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Boulder", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Layton, UT 84041", "state": "Georgia" }, { "city": "Bardstown", "state": "Kentucky" } ], "official_url": "https://clinicaltrials.gov/study/NCT00355121" }, { "nct_id": "NCT01049035", "title": "A Study of a Quadrivalent Meningococcal Tetanus Protein Conjugate Vaccine in Infants and Toddlers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningitis", "Meningococcal Infection" ], "interventions": [ { "name": "Quadrivalent Meningococcal Polysaccharide (A, C, Y, and W-135) Tetanus Protein Conjugate", "type": "BIOLOGICAL" }, { "name": "Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed, Inactivated Poliovirus and Haemophilus B Conjugate (Tetanus Toxoid Conjugate) Vaccine Combined (DTaP-IPV/Hib combined)", "type": "BIOLOGICAL" }, { "name": "M-M-RII-Measles, Mumps, and Rubella Virus Vaccine Live", "type": "BIOLOGICAL" }, { "name": "Varicella Virus Vaccine Live", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein)", "type": "BIOLOGICAL" }, { "name": "Pneumococcal 13-valent Conjugate Vaccine (Diphtheria CRM197 Protein)", "type": "BIOLOGICAL" }, { "name": "Rotavirus Vaccine", "type": "BIOLOGICAL" }, { "name": "Hepatitis B Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "42 Days", "maximum_age": "365 Days", "sex": "ALL", "summary": "42 Days to 365 Days" }, "enrollment_count": 580, "start_date": "2009-12-16", "completion_date": "2012-02-13", "has_results": true, "last_update_posted_date": "2022-03-28", "last_synced_at": "2026-06-11T01:35:02.224Z", "location_count": 25, "location_summary": "Birmingham, Alabama • Tuscaloosa, Alabama • Jonesboro, Arkansas + 20 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tuscaloosa", "state": "Alabama" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Fountain Valley", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01049035" }, { "nct_id": "NCT00258856", "title": "Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningitis", "Meningococcal Infection" ], "interventions": [ { "name": "Polysaccharide Diphtheria Conjugate Vaccine", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "7 Years", "maximum_age": "15 Years", "sex": "ALL", "summary": "7 Years to 15 Years" }, "enrollment_count": 234, "start_date": "2006-01", "completion_date": "2007-11", "has_results": true, "last_update_posted_date": "2014-02-14", "last_synced_at": "2026-06-11T01:35:02.224Z", "location_count": 11, "location_summary": "Jonesboro, Arkansas • Little Rock, Arkansas • Marietta, Georgia + 8 more", "locations": [ { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Marietta", "state": "Georgia" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Woburn", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00258856" }, { "nct_id": "NCT00700713", "title": "Antibody Persistence and Booster Dose Response in Subjects Who Received Menactra® Three Years Earlier in Study MTA26", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Meningitis", "Meningococcemia" ], "interventions": [ { "name": "Meningococcal polysaccharide diphtheria toxoid conjugate", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "Sanofi Pasteur, a Sanofi Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "3 Years", "maximum_age": "6 Years", "sex": "ALL", "summary": "3 Years to 6 Years" }, "enrollment_count": 181, "start_date": "2008-06", "completion_date": "2009-03", "has_results": true, "last_update_posted_date": "2016-02-15", "last_synced_at": "2026-06-11T01:35:02.224Z", "location_count": 13, "location_summary": "Marietta, Georgia • Woodstock, Georgia • Bardstown, Kentucky + 9 more", "locations": [ { "city": "Marietta", "state": "Georgia" }, { "city": "Woodstock", "state": "Georgia" }, { "city": "Bardstown", "state": "Kentucky" }, { "city": "Annapolis", "state": "Maryland" }, { "city": "Frederick", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00700713" }, { "nct_id": "NCT01978093", "title": "Immunogenicity, Safety and Reactogenicity Study of GlaxoSmithKline (GSK) Biologicals' Hib-MenCY-TT (MenHibrix®) Vaccine Compared to Merck & Co, Inc. PedvaxHIB Vaccine in Healthy Infants and Toddlers 12 to 15 Months of Age", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Neisseria Meningitidis", "Haemophilus Influenzae Type b" ], "interventions": [ { "name": "Hib-MenCY-TT (MenHibrix®)", "type": "BIOLOGICAL" }, { "name": "Pediarix®", "type": "BIOLOGICAL" }, { "name": "Rotarix®", "type": "BIOLOGICAL" }, { "name": "Prevnar 13®", "type": "BIOLOGICAL" }, { "name": "PedvaxHIB®", "type": "BIOLOGICAL" }, { "name": "Havrix®", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "6 Weeks", "maximum_age": "12 Weeks", "sex": "ALL", "summary": "6 Weeks to 12 Weeks" }, "enrollment_count": 600, "start_date": "2014-02-01", "completion_date": "2016-03-18", "has_results": true, "last_update_posted_date": "2018-09-14", "last_synced_at": "2026-06-11T01:35:02.224Z", "location_count": 26, "location_summary": "Birmingham, Alabama • Fayetteville, Arkansas • Jonesboro, Arkansas + 23 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Fayetteville", "state": "Arkansas" }, { "city": "Jonesboro", "state": "Arkansas" }, { "city": "Fresno", "state": "California" }, { "city": "Huntington Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01978093" } ] }